Visual analysis of tissue and cellular imaging is critical to defining and understanding stroke mechanisms. Ace Therapeutics offers a range of histological stains and specialty stains to help our customers achieve optimal staining results. Our range of staining products and supporting protocols are widely used in stroke research to help researchers better understand the structure and function of the nervous system and advance stroke science. Additionally, we provides antifade fluorescence mounting media range of products to help you acquire the quality of images and minimal signal intensity loss during research.
Tag: IHC and Histological Stains, Fluorescence Probes, Ion Indicators, Proteins and Antibodies Labeling, Antifades & Mounting Media
For more detailed staining protocols, please access a specific product or contact our scientists.
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-103 | DAPI Staining Solution (1mg/mL) (AC103) | 1 mL, 5 mL, | inquiry |
ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
ASSD-109 | Picro Sirius Red Solution (AC109) | 250 mL | inquiry |
ASSD-110 | Picro Sirius Red Stain Kit (AC110) | 1 kit, 100 tests | inquiry |
ASSD-111 | Propidium Iodide (AC111) | 10 mg, 50 mg | inquiry |
ASSD-112 | Propidium Iodide Staining Solution (1mg/ml) in water (AC112) | 1 mL | inquiry |
ASSD-113 | Thionin acetate salt (AC113) | 5 g | inquiry |
ASSD-114 | Acridine Orange hydrochloride (AC114) | 50 mg | inquiry |
ASSD-115 | 7-Amino-4-methylcoumarin (AC115) | 100 mg, 500 mg, 1 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.